BMY Financial Facts
Net Earnings: 1.22BNet Earnings Attributable to Noncontrolling Interest: 13M
See Full Income Statement
Accounts payable: 1.41B
Deferred income: 567M
See Full Balance Sheet
Bristol-Myers Squibb Company (BMY) Earnings
|
Expand Research on BMY
Next EPS Date | 4/25/24 | EPS Growth Rate | -318.0% |
---|---|---|---|
Average EPS % Beat Rate | +2.8% | Revenue Growth Rate | +1.4% |
Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
10/26/10 | Q310 | $0.59 | $0.53 | +$0.06 | N/A | N/A | N/A | Details | |||
1/27/11 | Q410 | $0.47 | $0.48 | -$0.01 | $5.1B | $5.04B | = | Details | |||
4/28/11 | Q111 | $0.58 | $0.53 | +$0.05 | $5.01B | $4.95B | = | Details | |||
7/28/11 | Q211 | $0.56 | $0.55 | +$0.01 | $5.4B | $5.04B | = | Details | |||
10/27/11 | Q311 | $0.61 | $0.58 | +$0.03 | $5.3B | $5.3B | = | Details | |||
1/26/12 | Q411 | $0.53 | $0.55 | -$0.02 | $5.45B | $5.5B | Details | ||||
4/26/12 | Q112 | $0.64 | $0.63 | +$0.01 | $5.25B | $5.26B | Details | ||||
7/25/12 | Q212 | $0.48 | $0.49 | -$0.01 | $4.44B | $4.44B | Details |